SCHEDULE SC 13D BY DOMAIN PARTNERS VII FOR OBALON THERAPEUTICS, INC.

Company

Vyome Holdings, Inc

Filed

August 31, 2018

Accession Number

0000904454-18-000545

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →